Maugel Completes R&D Facility for Spring Bank Pharmaceuticals

Spring Bank

Hopkinton, MA – Maugel Architects announced the completion of Spring Bank Pharmaceuticals’ new research and development facility in Hopkinton.

Located at 35 Parkwood Drive, Spring Bank will occupy 30,000sf of a 160,000sf building owned by Parsons Commercial Group, Inc. The space features multiple laboratories and office workspace.

Spring Bank’s versatile new facility has been designed with efficiency in mind, from the flow of moving between labs to the placement of specialized equipment.


In addition to Maugel Architects and Spring Bank, team members include Parsons Commercial Group, Colliers International, Venture Forward Partners, Fitzemeyer & Tocci Associates, and Walker Development.

The flexible lab environment maximizes natural light and allows for dynamic workspace reconfiguration to accommodate future needs. The modern lab spaces feature the latest technologies in life sciences design with laboratories for chemistry, biology, analytics, instrumentation.

“Maugel Architects has been designing R&D spaces for clients in the life sciences industry for close to 20 years,” said Mark Pelletier, senior director of architecture at Maugel Architects. “It was a pleasure working with the Spring Bank team to create a modern, flexible lab environment that will meet their needs today and tomorrow.”